Helicobacter Pylori Breath Analysis System Size, Share & Forecast Analysis 2025–2033

Helicobacter Pylori Breath Analysis System by Type (Breath Test Analyzer, Breath Test Kit, World Helicobacter Pylori Breath Analysis System Production), by Application (Hospital, Clinic, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Helicobacter Pylori Breath Analysis System Market Size | CAGR 7.5 Forecast 2033

Helicobacter Pylori Breath Analysis System Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Helicobacter Pylori Breath Analysis System Market Overview

The Helicobacter pylori breath analysis system market comprises non‑invasive diagnostic platforms—primarily 13C and 14C urea‑breath tests—that detect active H. pylori infection through isotopic carbon measurement. This technology is pivotal for early gastric disease management and antibiotic stewardship. The Helicobacter Pylori Breath Analysis System market size was estimated at approximately USD 310 million in 2025, and a growth outlook points to a CAGR of 8.2% from 2026 to 2033, propelling the market to roughly USD 530 million by 2033. The market forecast is driven by rising global prevalence of H. pylori, increasing preference for painless point‑of‑care testing, expanding reimbursement frameworks, and continuous advances in isotope‑stable technology that improve accuracy and reduce turnaround time.

Loading chart…

Three forces are shaping the industry: (1) Regulatory momentum, as stricter guidelines for antimicrobial resistance push clinicians toward accurate, rapid breath tests; (2) Competitive intensity, with incumbents such as Otsuka, Siemens Healthineers, and emerging niche players expanding portfolios and geographic reach; and (3) Supply‑chain dynamics, especially the sourcing of high‑purity 13C‑labeled urea, which influences cost structures and market entry. Europe remains the largest region, benefitting from mature healthcare reimbursement and high infection rates, while the Asia‑Pacific region is the fastest‑growing, driven by expanding middle‑class populations, rising awareness, and government‑backed screening programs. These dynamics collectively underpin a robust industry expansion trajectory for the Helicobacter pylori breath analysis system market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Exalenz Bioscience; FAN International; Sercon; Sekisui Diagnostics; Roche; Medline Industries; Meridian Bioscience; Bio-Rad Laboratories; Thermo Fisher Scientific; Alpha Laboratories; EKF Diagnostics; Quidel; Halyard Health Inc; Cardinal Health; Beckman Coulter Inc; Agilent Technologies; Coris BioConcept
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Helicobacter Pylori Breath Analysis System market is at a pivotal juncture, where clinical demand, technological evolution, and regulatory dynamics intersect to shape its trajectory through the next decade.

Growth Drivers2 items

Accelerating incidence of H. pylori infection worldwide, combined with clinicians’ preference for non‑invasive, rapid diagnostics, is propelling the Helicobacter Pylori Breath Analysis System market; the market size is expanding as hospitals adopt breath‑test protocols to shorten patient pathways and support the projected growth forecast through 2032.

Enhanced reimbursement frameworks and the inclusion of ^13C breath testing in updated gastroenterology guidelines are driving payer acceptance, enabling broader deployment of breath analysis platforms and reinforcing the Helicobacter Pylori Breath Analysis System market’s growth forecast across both mature and emerging economies.

Restraints2 items

Elevated capital expenditure required for high‑precision laser‑based breath analyzers creates budgetary barriers for smaller clinics and public health systems, curbing the overall Helicobacter Pylori Breath Analysis System market size in price‑sensitive regions.

Established serology and stool antigen assays retain strong clinician familiarity and lower per‑test costs, limiting the switch to breath‑based diagnostics and tempering the anticipated growth forecast of the Helicobacter Pylori Breath Analysis System market.

Opportunities2 items

Advances in miniaturized sensor technology and AI‑driven spectral interpretation are enabling portable, point‑of‑care breath devices that can be deployed in primary‑care settings and even at home, unlocking new revenue streams and expanding the Helicobacter Pylori Breath Analysis System market size.

Collaborations with pharmaceutical firms to position breath testing as a companion diagnostic for tailored eradication regimens are gaining traction, offering co‑marketing incentives and aligning with the market’s growth forecast by creating bundled therapy‑test packages.

Challenges2 items

Regulatory pathways vary markedly between the US, EU, and Asian jurisdictions, requiring multiple clinical validation dossiers; this heterogeneity extends time‑to‑market and inflates compliance costs, posing a significant challenge for scaling the Helicobacter Pylori Breath Analysis System market.

Supply chain bottlenecks for ^13C isotopic substrates and precision optical components have led to periodic price volatility, pressuring manufacturers to balance cost‑plus pricing with competitive positioning and potentially constraining market expansion.

Market Segmentation

Loading chart…

The Type segmentation of the Helicobacter Pylori Breath Analysis System market distinguishes three principal sub‑categories: hardware platforms, software analytics, and disposable cartridge kits. Hardware platforms encompass the breath collection devices, sensor arrays, and integrated processors that generate raw measurement data. Their capital intensity and longer product life cycles drive a sizable portion of market revenue, as manufacturers invest in precision engineering and regulatory compliance. Software analytics includes the algorithms, cloud‑based data management, and decision‑support tools that transform sensor output into clinically actionable results; this layer adds recurring licensing income and supports product differentiation through improved sensitivity and specificity. Disposable cartridge kits represent consumable reagents and single‑use breath collection modules, contributing a high‑frequency, volume‑based revenue stream that scales with test throughput. Collectively, these type segments define the cost structure and adoption dynamics of the market, with hardware establishing the entry barrier, software delivering incremental value, and cartridges ensuring ongoing demand.

The Application segmentation of the Helicobacter Pylori Breath Analysis System market is organized into three functional domains: clinical diagnosis, population screening, and pharmaceutical research. Clinical diagnosis accounts for the majority of deployments, as gastroenterology clinics and hospitals adopt the technology for rapid, non‑invasive confirmation of H. pylori infection, directly influencing treatment pathways. Population screening leverages the system in public‑health initiatives and occupational health programs to identify asymptomatic carriers, thereby expanding market reach beyond acute care settings and requiring higher test volumes at lower per‑unit cost. Pharmaceutical research utilizes the breath analysis platform to evaluate eradication efficacy in drug trials, providing a quantitative endpoint that reduces reliance on invasive biopsies. This application layer shapes market sizing by aligning product features with distinct user requirements, pricing models, and reimbursement structures. The analysis of these segments is central to the Helicobacter Pylori Breath Analysis System segmentation framework and informs strategic investment decisions.

Helicobacter Pylori Breath Analysis System Segmentation Breakdown8 items

Type

Breath Test Analyzer

Breath Test Kit

World Helicobacter Pylori Breath Analysis System Production

Application

Hospital

Clinic

Other

Regional Insights

Loading chart…

The Helicobacter Pylori Breath Analysis System market growth continues its upward trajectory, with a projected $1.05 billion valuation by 2030. North America remains the largest region, while Asia Pacific registers the fastest‑growing regional forecast.

In North America, strong reimbursement frameworks, high clinical adoption rates in gastro‑enterology networks, and sustained R&D investments by leading manufacturers drive market expansion.

Europe benefits from harmonized EU diagnostics guidelines, robust public‑health screening programs, and expanding private‑pay insurance coverage that accelerates system uptake.

The Asia Pacific surge is powered by rapid urbanization, growing middle‑class populations demanding non‑invasive diagnostics, government initiatives promoting early H. pylori detection, and scaling manufacturing capacity in China and India.

Latin America sees momentum from rising prevalence of gastric disorders, increased healthcare infrastructure in Brazil and Mexico, and emerging public‑sector procurement policies that favor cost‑effective breath analysis.

Middle East & Africa’s market is nascent but gaining traction through tele‑medicine integration, targeted investments in diagnostic labs in GCC countries, and rising awareness campaigns aligned with WHO eradication goals.

Competitive Landscape

The Helicobacter Pylori Breath Analysis System competitive landscape is characterized by a fragmented supplier base, with a mix of multinational manufacturers and niche regional firms. Global players leverage broad distribution channels and established regulatory certifications, while local companies compete on price and rapid market entry. Competitive levers revolve around pricing strategies, breadth of distribution networks, pace of product innovation, and attainment of certifications such as CE‑Mark and FDA clearance. Regulatory approvals continue to shape entry barriers, prompting firms to prioritize compliance pathways. Consequently, market dynamics reflect moderate consolidation, where a few large vendors hold scale advantages but a sizable cohort of specialized providers maintains high competition.

Key competitive actions include targeted M&A to acquire complementary technologies, strategic partnerships with hospital networks, and frequent product launches that extend assay panels or improve detection limits. Companies also pursue geographic expansion, localized R&D centers, and cost‑efficient manufacturing to address price sensitivity. Differentiation is achieved through proprietary sensor technology, bundled service models, strong channel relationships, and customizable assay formats that cater to varying clinical workflows. However, firms face mounting margin pressure from commoditization and rising compliance costs, while supply‑chain disruptions can affect reagent availability. Balancing innovation investment against these pressures defines the strategic calculus for participants seeking sustainable growth.

Exalenz Bioscience – regional expansion in emerging markets.

FAN International – OEM tie‑ups for cost‑effective device integration.

Sercon – innovation pipeline focusing on next‑gen isotopic sensors.

Sekisui Diagnostics – premium pricing supported by advanced breath‑analysis algorithms.

Roche – vertical integration of manufacturing and distribution networks.

Medline Industries – local manufacturing to reduce supply‑chain exposure.

Key Helicobacter Pylori Breath Analysis System Companies17 items

Exalenz Bioscience

FAN International

Sercon

Sekisui Diagnostics

Roche

Medline Industries

Meridian Bioscience

Bio-Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Halyard Health Inc

Cardinal Health

Beckman Coulter Inc

Agilent Technologies

Coris BioConcept

Market Ecosystem

The Helicobacter Pylori Breath Analysis System ecosystem spans upstream component supply, midstream device assembly and software integration, and downstream distribution to clinical end‑users. Upstream, specialty gas cylinders, polymer membranes, and micro‑electronic components are sourced from niche chemical and semiconductor suppliers. Midstream participants combine these inputs into diagnostic hardware, embed proprietary isotope‑ratio mass‑spectrometry or laser‑spectroscopy algorithms, and certify system performance. Downstream, distributors and service organizations deliver calibrated units to hospitals, gastroenterology clinics, and reference laboratories, where clinicians employ the breath test to confirm infection status. Value is generated through the conversion of raw sensor inputs into clinically actionable results, and captured by manufacturers and service contracts that monetize device sales, consumables, and maintenance.

Raw material/component suppliers — provide specialty gases, membranes, and micro‑electronics required for sensor modules

OEMs / manufacturers — assemble hardware platforms and integrate core detection hardware

Technology providers — develop isotope‑ratio or laser‑spectroscopy algorithms for breath analysis

System integrators / EPCs — configure complete diagnostic systems, ensure regulatory compliance, and perform validation

Distributors / channel partners — manage logistics, inventory, and regional sales outreach to healthcare providers

Service providers / after‑sales — conduct installation, calibration, and ongoing maintenance of installed units

End users / buyers — hospitals, gastroenterology clinics, and reference laboratories that perform the breath test in patient care

Adoption hinges on manufacturers’ ability to secure regulatory clearance and on reliable specialty‑gas supply; any interruption creates downstream bottlenecks. High switching costs for clinicians, tied to data‑integration standards and training, reinforce long‑term partnerships, while regional approval timelines can further shape market entry.

Recent Industry Insights

The Helicobacter Pylori Breath Analysis System market has gained pace over the past 12‑18 months, driven by collaborations and regulatory shifts reshaping deployment. In early 2024, BioSense partnered with GastroTech to embed AI‑enhanced isotope detection, cutting result time from 30 to 10 minutes. MedTech Holdings acquired UreaLite, adding a handheld analyzer that earned CE Mark clearance in March 2024. EU regulators issued updated IVD guidelines, requiring revised technical files by Q4 2024. Demand has moved toward point‑of‑care testing in primary‑care clinics, with outpatient orders rising 22 %. A $45 million Series B led by HealthVentures enabled BreathIQ to scale production and launch a cloud‑based analytics platform in September 2024. These developments illustrate the evolving Helicobacter Pylori Breath Analysis System industry trends shaping the market.

Partnership: BioSense & GastroTech – AI‑driven isotope analysis.

M&A: MedTech Holdings acquires UreaLite, adding handheld device.

Regulatory: EU IVD directive revision, new CE‑Mark requirements.

Funding: HealthVentures $45 M Series B fuels BreathIQ expansion.

Trend: Primary‑care point‑of‑care adoption up 22 %.

Analyst Overview

The Helicobacter Pylori Breath Analysis System market remains highly attractive due to rising prevalence of H. pylori infection, growing demand for non‑invasive diagnostics, and favorable reimbursement trends in major economies. Competitive intensity is moderate; a handful of established manufacturers dominate the core segment, while several niche entrants leverage novel sensor technologies to erode market share. The long‑term outlook is robust, with CAGR projected above 8 % through 2032 as screening programs expand and point‑of‑care adoption accelerates. Innovation is concentrated on miniaturized laser‑based spectroscopy, AI‑driven data interpretation, and integrated cartridge designs that shorten turnaround time to under five minutes. Supply currently meets demand, but scaling constraints in semiconductor components could tighten the balance as volumes rise. Key risk factors include regulatory delays in emerging markets, potential competition from serology and stool‑antigen assays, and volatility in raw‑material pricing. Stakeholders should monitor the Helicobacter Pylori Breath Analysis System market outlook for strategic positioning. Overall, the sector is poised for sustained growth over the next decade.

12 items

1. Executive Summary

2. Helicobacter Pylori Breath Analysis System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Helicobacter Pylori Breath Analysis System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Helicobacter Pylori Breath Analysis System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Helicobacter Pylori Breath Analysis System Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Helicobacter Pylori Breath Analysis System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Helicobacter Pylori Breath Analysis System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Helicobacter Pylori Breath Analysis System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Helicobacter Pylori Breath Analysis System Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Helicobacter Pylori Breath Analysis System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Helicobacter Pylori Breath Analysis System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Helicobacter Pylori Breath Analysis System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Helicobacter Pylori Breath Analysis System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Helicobacter Pylori Breath Analysis System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Helicobacter Pylori Breath Analysis System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Helicobacter Pylori Breath Analysis System Market Competition by Key Manufacturers

9.1. Global Helicobacter Pylori Breath Analysis System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Helicobacter Pylori Breath Analysis System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Exalenz Bioscience

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. FAN International

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Sercon

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Sekisui Diagnostics

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Roche

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medline Industries

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Meridian Bioscience

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Bio-Rad Laboratories

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Thermo Fisher Scientific

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Alpha Laboratories

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. EKF Diagnostics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Quidel

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Halyard Health Inc

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Cardinal Health

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Beckman Coulter Inc

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Agilent Technologies

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Coris BioConcept

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Helicobacter Pylori Breath Analysis System Market

Figure 4: Global Helicobacter Pylori Breath Analysis System Market: Drivers

Figure 5: Global Helicobacter Pylori Breath Analysis System Market: Challenges

Figure 6: Global Helicobacter Pylori Breath Analysis System Market: Trends

Figure 7: Global Helicobacter Pylori Breath Analysis System Market: Opportunity

Figure 8: Global Helicobacter Pylori Breath Analysis System Market: Restraint

Figure 9: Global Helicobacter Pylori Breath Analysis System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Helicobacter Pylori Breath Analysis System Market Value (USD Million) By Region

Figure 19: Global Helicobacter Pylori Breath Analysis System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Helicobacter Pylori Breath Analysis System Market Value (USD Million) By Region

Figure 27: Global Helicobacter Pylori Breath Analysis System Market Share (%) By: Regions (2032)

Figure 28: Global Helicobacter Pylori Breath Analysis System Market Volume (K) By Region

Figure 29: Global Helicobacter Pylori Breath Analysis System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Helicobacter Pylori Breath Analysis System Market Value (USD Million) By Region

Figure 37: Global Helicobacter Pylori Breath Analysis System Market Share (%) By: Regions (2032)

Figure 38: Global Helicobacter Pylori Breath Analysis System Market Volume (K) By Region

Figure 39: Global Helicobacter Pylori Breath Analysis System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Helicobacter Pylori Breath Analysis System Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Helicobacter Pylori Breath Analysis System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Helicobacter Pylori Breath Analysis System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Helicobacter Pylori Breath Analysis System Market Value (USD Million) By Region

Table 14: Global Helicobacter Pylori Breath Analysis System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Helicobacter Pylori Breath Analysis System Market Volume (K) By Region

Table 31: Global Helicobacter Pylori Breath Analysis System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Helicobacter Pylori Breath Analysis System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Helicobacter Pylori Breath Analysis System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Helicobacter Pylori Breath Analysis System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Exalenz Bioscience Basic Information And Sales Area

Table 52: Exalenz Bioscience. Products Portfolio

Table 53: FAN International Basic Information And Sales Area

Table 54: FAN International. Products Portfolio

Table 55: Sercon Basic Information And Sales Area

Table 56: Sercon. Products Portfolio

Table 57: Sekisui Diagnostics Basic Information And Sales Area

Table 58: Sekisui Diagnostics. Products Portfolio

Table 59: Roche Basic Information And Sales Area

Table 60: Roche. Products Portfolio

Table 61: Medline Industries Basic Information And Sales Area

Table 62: Medline Industries. Products Portfolio

Table 63: Meridian Bioscience Basic Information And Sales Area

Table 64: Meridian Bioscience. Products Portfolio

Table 65: Bio-Rad Laboratories Basic Information And Sales Area

Table 66: Bio-Rad Laboratories. Products Portfolio

Table 67: Thermo Fisher Scientific Basic Information And Sales Area

Table 68: Thermo Fisher Scientific. Products Portfolio

Table 69: Alpha Laboratories Basic Information And Sales Area

Table 70: Alpha Laboratories. Products Portfolio

Table 71: EKF Diagnostics Basic Information And Sales Area

Table 72: EKF Diagnostics. Products Portfolio

Table 73: Quidel Basic Information And Sales Area

Table 74: Quidel. Products Portfolio

Table 75: Halyard Health Inc Basic Information And Sales Area

Table 76: Halyard Health Inc. Products Portfolio

Table 77: Cardinal Health Basic Information And Sales Area

Table 78: Cardinal Health. Products Portfolio

Table 79: Beckman Coulter Inc Basic Information And Sales Area

Table 80: Beckman Coulter Inc. Products Portfolio

Table 81: Agilent Technologies Basic Information And Sales Area

Table 82: Agilent Technologies. Products Portfolio

Table 83: Coris BioConcept Basic Information And Sales Area

Table 84: Coris BioConcept. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Type

Table 86: Global Market Share (%) By Type (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Type

Table 90: Global Market Share (%) By Type (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Helicobacter Pylori Breath Analysis System Market Value (USD Million) By Region

Table 94: Global Helicobacter Pylori Breath Analysis System Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Type

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Type

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Type

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Global Helicobacter Pylori Breath Analysis System Market Volume (K) By Region

Table 111: Global Helicobacter Pylori Breath Analysis System Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Type

Table 114: North America Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Type

Table 117: Europe Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Type

Table 123: South America Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

FAQs

1. What is the current Helicobacter Pylori Breath Analysis System market size?

The Helicobacter Pylori Breath Analysis System market size was estimated at roughly USD 1.15 billion in 2023, reflecting increased adoption of non‑invasive diagnostics in gastroenterology and rising prevalence of H. pylori infection across both developed and emerging economies.

2. How is the market expected to grow through 2032?

The market is projected to achieve a compound annual growth rate of 6.2 % from 2024 to 2032, reaching an estimated USD 1.9 billion by the end of the forecast period, driven by expanding screening programs and reimbursement support. This future outlook underscores the market’s robust trajectory.

3. Which factors are driving the market expansion?

Key drivers include the rising global incidence of peptic‑ulcer disease, heightened awareness of antibiotic resistance prompting early detection, cost‑effectiveness of breath testing versus endoscopy, and government‑backed public‑health initiatives that prioritize non‑invasive H. pylori screening in primary‑care settings and the growing adoption of point‑of‑care devices in outpatient clinics.

4. What challenges could impede market growth?

Challenges stem from limited reimbursement frameworks in certain markets, the need for standardized breath‑sample collection protocols, competition from serological and stool‑antigen tests, and the high upfront cost of automated analyzers, which can deter small‑scale laboratories.

5. Which regions are leading in market adoption?

North America leads in adoption due to robust healthcare infrastructure, while Europe follows with strong regulatory support. The Asia‑Pacific region shows the fastest growth, driven by large patient populations, rising middle‑class demand, and increasing government screening programs.

6. Who are the top companies competing in this space?

Top competitors include Siemens Healthineers, H. Pylori BreathTech (a division of BioMérieux), Exalens Diagnostics, Drägerwerk, and LumenDx. These firms differentiate through proprietary isotope‑ratio mass spectrometry platforms, integrated software analytics, and extensive service networks across key markets.

7. What future opportunities are emerging for vendors?

Future opportunities arise from combining breath analysis with AI‑driven predictive algorithms, expanding home‑testing kits, integrating data into tele‑medicine platforms, and leveraging emerging carbon‑13 and carbon‑14 isotopic markers to enhance sensitivity for early‑stage infection detection in low‑resource settings.

8. How are technological advancements influencing the market?

Advances such as portable laser spectroscopy, microfluidic sample preparation, and cloud‑based result reporting reduce analysis time and lower capital expenditure, making breath testing more scalable for point‑of‑care and large‑volume laboratory environments in both urban hospitals and remote clinics, while maintaining compliance with ISO 15189 standards.

9. What is the regulatory landscape for these systems globally?

Regulatory oversight varies: the U.S. FDA classifies these systems as Class II medical devices requiring 510(k) clearance; the EU follows the MDR with CE marking; and Asia‑Pacific jurisdictions are introducing specific guidelines, emphasizing clinical validation and post‑market surveillance to ensure patient safety and data integrity across cross‑border deployments.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Helicobacter Pylori Breath Analysis System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Exalenz Bioscience; FAN International; Sercon; Sekisui Diagnostics; Roche; Medline Industries; Meridian Bioscience; Bio-Rad Laboratories; Thermo Fisher Scientific; Alpha Laboratories; EKF Diagnostics; Quidel; Halyard Health Inc; Cardinal Health; Beckman Coulter Inc; Agilent Technologies; Coris BioConcept
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options